In another investigation, although 60% of subjects with CKD have CAD, plasma levels of adiponectin were not decreased in subjects with CRF compared with controls (17.02±9.8 versus 16.40±9.0; P=0.78). This evidence concerns the gene ADIPOQ and chronic kidney disease.